XML 66 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Income (USD $)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Income Statement [Abstract]      
Net revenues $ 126,761 $ 123,120 $ 107,080
Cost of revenues 102,978 100,632 86,518
Gross profit 23,783 22,488 20,562
Operating expenses 15,746 15,278 14,231
Operating profit 8,037 7,210 6,331
Interest expense, net 509 557 584
Loss on early extinguishment of debt 0 348 0
Income before income tax provision 7,528 6,305 5,747
Income tax provision 2,928 2,436 2,258
Income from continuing operations 4,600 3,869 3,489
Loss from discontinued operations, net of tax (8) (7) (31)
Net income 4,592 3,862 3,458
Net loss attributable to noncontrolling interest 0 2 4
Net income attributable to CVS Caremark $ 4,592 $ 3,864 $ 3,462
Basic earnings per common share:      
Income from continuing operations attributable to CVS Caremark (in dollars per share) $ 3.78 $ 3.05 $ 2.61
Loss from discontinued operations attributable to CVS Caremark (in dollars per share) $ (0.01) $ (0.01) $ (0.02)
Net income attributable to CVS Caremark (in dollars per share) $ 3.77 $ 3.04 $ 2.59
Weighted average common shares outstanding (in shares) 1,217 1,271 1,338
Diluted earnings per common share:      
Income from continuing operations attributable to CVS Caremark (in dollars per share) $ 3.75 $ 3.02 $ 2.59
Loss from discontinued operations attributable to CVS Caremark (in dollars per share) $ (0.01) $ (0.01) $ (0.02)
Net income attributable to CVS Caremark (in dollars per share) $ 3.74 $ 3.02 $ 2.57
Weighted average common shares outstanding (in shares) 1,226 1,280 1,347
Dividends declared per common share $ 0.9 $ 0.65 $ 0.50